Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Cut to Hold at Jefferies Financial Group

Jefferies Financial Group lowered shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) from a buy rating to a hold rating in a research note issued to investors on Monday, MarketBeat reports.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance

OTCMKTS:MURGY opened at $10.17 on Monday. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.12 and a quick ratio of 1.12. The company has a 50 day moving average price of $52.65 and a 200-day moving average price of $49.71. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 1-year low of $7.86 and a 1-year high of $11.14. The firm has a market cap of $13.88 billion, a price-to-earnings ratio of 13.96, a price-to-earnings-growth ratio of 0.69 and a beta of 1.02.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) last issued its quarterly earnings data on Thursday, August 8th. The financial services provider reported $1.31 EPS for the quarter, beating the consensus estimate of $1.24 by $0.07. The business had revenue of $16.10 billion during the quarter. Equities research analysts forecast that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München will post 5.75 EPS for the current year.

About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.